nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—vein—ovarian cancer	0.38	0.655	CbGeAlD
Ximelagatran—F2—epithelium—ovarian cancer	0.0588	0.101	CbGeAlD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—SELENBP1—ovarian cancer	0.0582	0.139	CbGpPWpGaD
Ximelagatran—F2—female reproductive system—ovarian cancer	0.0436	0.0751	CbGeAlD
Ximelagatran—F2—bone marrow—ovarian cancer	0.0412	0.0709	CbGeAlD
Ximelagatran—F2—female gonad—ovarian cancer	0.0397	0.0683	CbGeAlD
Ximelagatran—F2—Folate Metabolism—FOLR1—ovarian cancer	0.0342	0.0816	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—RRAS2—ovarian cancer	0.0277	0.066	CbGpPWpGaD
Ximelagatran—CYP2C9—female reproductive system—ovarian cancer	0.0174	0.0299	CbGeAlD
Ximelagatran—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.0137	0.0328	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.0125	0.0298	CbGpPWpGaD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—MMP2—ovarian cancer	0.0103	0.0245	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—MUC16—ovarian cancer	0.00906	0.0216	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD1—ovarian cancer	0.00856	0.0204	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD2—ovarian cancer	0.00771	0.0184	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SOD1—ovarian cancer	0.00697	0.0166	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—MMP9—ovarian cancer	0.00694	0.0166	CbGpPWpGaD
Ximelagatran—CYP2C9—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00634	0.0151	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SOD2—ovarian cancer	0.00627	0.015	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD1—ovarian cancer	0.00553	0.0132	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—MMP9—ovarian cancer	0.00551	0.0132	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—ovarian cancer	0.00513	0.0123	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD2—ovarian cancer	0.00498	0.0119	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—PIK3CA—ovarian cancer	0.00487	0.0116	CbGpPWpGaD
Ximelagatran—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK3—ovarian cancer	0.00468	0.0112	CbGpPWpGaD
Ximelagatran—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK1—ovarian cancer	0.00446	0.0106	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MUC16—ovarian cancer	0.0043	0.0103	CbGpPWpGaD
Ximelagatran—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00373	0.00891	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—CAV1—ovarian cancer	0.00368	0.00879	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.00365	0.00871	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00355	0.00848	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RAD51C—ovarian cancer	0.00352	0.0084	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK3—ovarian cancer	0.00328	0.00783	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL2—ovarian cancer	0.00326	0.0078	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.00317	0.00757	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—ovarian cancer	0.00312	0.00745	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—PIK3CA—ovarian cancer	0.00305	0.00729	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—AKT1—ovarian cancer	0.00281	0.00672	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—INHA—ovarian cancer	0.00277	0.00661	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00274	0.00654	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—ovarian cancer	0.00271	0.00646	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.0027	0.00646	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.00265	0.00633	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CB—ovarian cancer	0.00257	0.00614	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.00245	0.00585	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CG—ovarian cancer	0.00242	0.00577	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—APC—ovarian cancer	0.00242	0.00577	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—ovarian cancer	0.00236	0.00563	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00222	0.0053	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—ovarian cancer	0.00221	0.00528	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CD—ovarian cancer	0.00213	0.00508	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—ovarian cancer	0.0021	0.00501	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HSD17B6—ovarian cancer	0.00202	0.00483	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—NRAS—ovarian cancer	0.00198	0.00473	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—TUBB3—ovarian cancer	0.00195	0.00466	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—ovarian cancer	0.00192	0.00458	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SPARC—ovarian cancer	0.00188	0.00449	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	0.00188	0.00448	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CB—ovarian cancer	0.00185	0.00442	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.00176	0.00421	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DLC1—ovarian cancer	0.00172	0.00411	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—KRAS—ovarian cancer	0.00171	0.00407	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ATF3—ovarian cancer	0.00165	0.00393	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CA—ovarian cancer	0.00157	0.00374	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.00155	0.0037	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—ovarian cancer	0.00152	0.00364	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.00147	0.0035	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—HRAS—ovarian cancer	0.00145	0.00346	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—NRAS—ovarian cancer	0.00143	0.00341	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BCL9—ovarian cancer	0.0014	0.00335	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK3—ovarian cancer	0.00137	0.00327	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SOD1—ovarian cancer	0.00137	0.00326	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PPP2R1A—ovarian cancer	0.00136	0.00324	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.00135	0.00323	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK1—ovarian cancer	0.0013	0.00311	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGFR—ovarian cancer	0.0013	0.00311	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.00124	0.00296	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—KRAS—ovarian cancer	0.00123	0.00294	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.00118	0.00282	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00116	0.00278	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CA—ovarian cancer	0.00113	0.0027	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DOK1—ovarian cancer	0.00111	0.00265	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	0.00107	0.00254	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.00106	0.00252	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP1CC—ovarian cancer	0.00104	0.00249	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	0.00102	0.00244	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CAV1—ovarian cancer	0.000998	0.00238	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	0.000998	0.00238	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000983	0.00235	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	0.000971	0.00232	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	0.000971	0.00232	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	0.00095	0.00227	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PIK3CA—ovarian cancer	0.000942	0.00225	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	0.000917	0.00219	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00091	0.00217	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CG—ovarian cancer	0.000909	0.00217	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	0.000843	0.00201	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	0.000824	0.00197	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CD—ovarian cancer	0.0008	0.00191	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HDAC6—ovarian cancer	0.00079	0.00189	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PPP2R1A—ovarian cancer	0.00078	0.00186	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	0.000779	0.00186	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—ovarian cancer	0.000749	0.00179	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	0.000746	0.00178	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NME2—ovarian cancer	0.000719	0.00172	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—YAP1—ovarian cancer	0.0007	0.00167	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CB—ovarian cancer	0.000697	0.00166	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—XIAP—ovarian cancer	0.000685	0.00164	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	0.000673	0.00161	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SMARCA4—ovarian cancer	0.000668	0.00159	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EREG—ovarian cancer	0.000652	0.00156	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—ovarian cancer	0.00064	0.00153	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—ovarian cancer	0.000634	0.00151	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PGR—ovarian cancer	0.000611	0.00146	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00061	0.00146	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000575	0.00137	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PARP1—ovarian cancer	0.000568	0.00136	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—ovarian cancer	0.000544	0.0013	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6ST—ovarian cancer	0.000543	0.0013	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NRAS—ovarian cancer	0.000537	0.00128	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—ovarian cancer	0.000527	0.00126	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CG—ovarian cancer	0.000522	0.00125	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK3—ovarian cancer	0.000515	0.00123	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000505	0.00121	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000497	0.00119	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK1—ovarian cancer	0.00049	0.00117	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTNNB1—ovarian cancer	0.000486	0.00116	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYTB—ovarian cancer	0.000464	0.00111	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—ovarian cancer	0.000462	0.0011	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP2R1A—ovarian cancer	0.000461	0.0011	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CD—ovarian cancer	0.000459	0.0011	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000453	0.00108	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CB—ovarian cancer	0.00044	0.00105	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—ovarian cancer	0.000425	0.00101	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—ovarian cancer	0.000423	0.00101	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—ovarian cancer	0.000411	0.000981	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPP1CC—ovarian cancer	0.000405	0.000967	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BRIP1—ovarian cancer	0.000405	0.000967	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—ovarian cancer	0.000404	0.000966	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CB—ovarian cancer	0.0004	0.000955	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HRAS—ovarian cancer	0.000393	0.000938	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—ovarian cancer	0.000384	0.000918	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—ovarian cancer	0.000367	0.000877	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TERT—ovarian cancer	0.000366	0.000874	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—ovarian cancer	0.000347	0.000829	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CAV1—ovarian cancer	0.000339	0.000808	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—ovarian cancer	0.000326	0.000779	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6ST—ovarian cancer	0.000321	0.000766	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APC—ovarian cancer	0.000308	0.000736	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CG—ovarian cancer	0.000308	0.000736	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NRAS—ovarian cancer	0.000308	0.000736	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK3—ovarian cancer	0.000295	0.000705	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000295	0.000705	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK1—ovarian cancer	0.000281	0.000671	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—ovarian cancer	0.000281	0.000671	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—YAP1—ovarian cancer	0.000272	0.000649	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CD—ovarian cancer	0.000271	0.000647	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000269	0.000642	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000268	0.000641	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—ovarian cancer	0.000265	0.000634	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—ovarian cancer	0.000244	0.000582	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB2—ovarian cancer	0.000239	0.000572	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000236	0.000564	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MTOR—ovarian cancer	0.000236	0.000564	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CB—ovarian cancer	0.000236	0.000564	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—ovarian cancer	0.000227	0.000542	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HRAS—ovarian cancer	0.000226	0.000539	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1B—ovarian cancer	0.000222	0.000529	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FASN—ovarian cancer	0.000222	0.000529	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—ovarian cancer	0.000219	0.000524	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A5—ovarian cancer	0.000218	0.00052	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—ovarian cancer	0.000217	0.000519	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—ovarian cancer	0.000217	0.000518	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—ovarian cancer	0.000216	0.000515	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—ovarian cancer	0.000212	0.000505	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A1—ovarian cancer	0.00021	0.000502	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CTNNB1—ovarian cancer	0.000209	0.0005	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000206	0.000492	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—ovarian cancer	0.000205	0.00049	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—ovarian cancer	0.000204	0.000487	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1B1—ovarian cancer	0.000202	0.000482	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—ovarian cancer	0.000199	0.000476	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—ovarian cancer	0.000184	0.00044	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—ovarian cancer	0.000183	0.000436	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NRAS—ovarian cancer	0.000182	0.000435	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	0.000179	0.000427	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000178	0.000425	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK3—ovarian cancer	0.000174	0.000416	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—ovarian cancer	0.00017	0.000405	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCB1—ovarian cancer	0.000166	0.000397	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK1—ovarian cancer	0.000166	0.000396	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—ovarian cancer	0.000166	0.000396	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMS—ovarian cancer	0.000163	0.00039	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—ovarian cancer	0.000157	0.000374	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—ovarian cancer	0.000144	0.000344	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—ovarian cancer	0.000139	0.000333	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRAS—ovarian cancer	0.000133	0.000318	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAV1—ovarian cancer	0.000131	0.000314	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—ovarian cancer	0.000128	0.000305	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000126	0.0003	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CG—ovarian cancer	0.00012	0.000286	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—ovarian cancer	0.000118	0.000281	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CD—ovarian cancer	0.000105	0.000251	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CB—ovarian cancer	9.18e-05	0.000219	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—ovarian cancer	7.93e-05	0.000189	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—ovarian cancer	5.59e-05	0.000134	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—ovarian cancer	4.57e-05	0.000109	CbGpPWpGaD
